Toggle Dropdown
Announcements
Projects
News & Events
Welcome guest
Log in
Loading
Loading...
https://www.sciencedaily.com/releases/2022/09/220908120508.htm
0
0
Promising anti-cancer drug also may function as COVID-19 antiviral therapy: Study suggests small molecule inhibitor RK-33 can block multiple variants of the SARS-CoV-2 virus from replicating - Science Daily
9/8/22 at 5:15pm
Organization
Science Daily
74 words
0
Comments
Findings from a new study suggest that an effective means of fighting SARS-CoV-2, the virus that causes COVID-19, may be possible that circumvents the problem of waning immunity often observed when current vaccines deal with emerging COVID variants.
Cancer
Health
Drugs & Medications
Infectious Diseases
SARS-CoV-2
anti-cancer drug
RK-33
SARS-CoV
You are the first to view
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...